BACKGROUND: Whilst the number of people living in nursing homes (NH) is expected to rise, research on NH quality is scarce. The purpose of this article is to describe the research protocol of the IQUARE study and to present its baseline data. METHODS AND DESIGN: IQUARE is a 18-month multicentric individually-tailored controlled trial of education and professional support to NH staff. The main purposes of IQUARE are to improve the quality of the health care provided in NHs and to reduce the risk of functional decline among residents. Data on internal organisation and residents' health for the 175 participating NHs were recorded by NH staff at baseline. NHs were allocated to either a light intervention group (LIG, n = 90 NHs, totalising 3 258 participants) or a strong intervention group (SIG, n = 85 NHs, totalising 3 017 participants). Intervention for LIG consisted at delivering to NH staff descriptive statistics on indicators of quality regarding their NH and the NHs from their sub-region of health and region; whereas for SIG, NH staff received the same information that LIG, but quality indicators were discussed by a cooperative work (two half-day meetings) between a hospital geriatrician and NH staff. Strategies for overcoming NH's weaknesses were then traced; the efficacy of strategies is evaluated at a 6-month period. RESULTS: Baseline data showed high levels of dependence, comorbidities, psychological disturbances and medication's consumption among NH residents. Large discrepancies among NHs were observed. CONCLUSIONS: IQUARE is one of the largest controlled trials in NHs developed in France. Results from IQUARE may constitute the basis for the development of new work modalities within the French health system, and serve as a model of a feasible research approach in NHs.
BACKGROUND: Whilst the number of people living in nursing homes (NH) is expected to rise, research on NH quality is scarce. The purpose of this article is to describe the research protocol of the IQUARE study and to present its baseline data. METHODS AND DESIGN: IQUARE is a 18-month multicentric individually-tailored controlled trial of education and professional support to NH staff. The main purposes of IQUARE are to improve the quality of the health care provided in NHs and to reduce the risk of functional decline among residents. Data on internal organisation and residents' health for the 175 participating NHs were recorded by NH staff at baseline. NHs were allocated to either a light intervention group (LIG, n = 90 NHs, totalising 3 258 participants) or a strong intervention group (SIG, n = 85 NHs, totalising 3 017 participants). Intervention for LIG consisted at delivering to NH staff descriptive statistics on indicators of quality regarding their NH and the NHs from their sub-region of health and region; whereas for SIG, NH staff received the same information that LIG, but quality indicators were discussed by a cooperative work (two half-day meetings) between a hospital geriatrician and NH staff. Strategies for overcoming NH's weaknesses were then traced; the efficacy of strategies is evaluated at a 6-month period. RESULTS: Baseline data showed high levels of dependence, comorbidities, psychological disturbances and medication's consumption among NH residents. Large discrepancies among NHs were observed. CONCLUSIONS: IQUARE is one of the largest controlled trials in NHs developed in France. Results from IQUARE may constitute the basis for the development of new work modalities within the French health system, and serve as a model of a feasible research approach in NHs.
Authors: Jessina C McGregor; Peter W Kim; Eli N Perencevich; Douglas D Bradham; Jon P Furuno; Keith S Kaye; Jeffrey C Fink; Patricia Langenberg; Mary-Claire Roghmann; Anthony D Harris Journal: Am J Epidemiol Date: 2005-03-01 Impact factor: 4.897
Authors: Y Rolland; G Abellan van Kan; S Hermabessiere; S Gerard; S Guyonnet Gillette; B Vellas Journal: J Nutr Health Aging Date: 2009-10 Impact factor: 4.075
Authors: F Lattanzio; C Mussi; E Scafato; C Ruggiero; G Dell'Aquila; C Pedone; F Mammarella; L Galluzzo; G Salvioli; U Senin; P U Carbonin; R Bernabei; A Cherubini Journal: J Nutr Health Aging Date: 2010-03 Impact factor: 4.075
Authors: Graziano Onder; Iain Carpenter; Harriet Finne-Soveri; Jacob Gindin; Dinnus Frijters; Jean Claude Henrard; Thorsten Nikolaus; Eva Topinkova; Matteo Tosato; Rosa Liperoti; Francesco Landi; Roberto Bernabei Journal: BMC Health Serv Res Date: 2012-01-09 Impact factor: 2.655
Authors: S Sourdet; C Rochette; P de Souto Barreto; F Nourhashemi; A Piau; B Vellas; Y Rolland Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Y Rolland; P de Souto Barreto; G Abellan Van Kan; C Annweiler; O Beauchet; H Bischoff-Ferrari; G Berrut; H Blain; M Bonnefoy; M Cesari; G Duque; M Ferry; O Guerin; O Hanon; B Lesourd; J Morley; A Raynaud-Simon; G Ruault; J-C Souberbielle; B Vellas Journal: J Nutr Health Aging Date: 2013-04 Impact factor: 4.075
Authors: Antoine Piau; Fati Nourhashemi; Adélaïde De Mauléon; Achille Tchalla; Claude Vautier; Bruno Vellas; Maryline Duboue; Nadège Costa; Pierre Rumeau; Benoit Lepage; Maria Soto Martin Journal: BMJ Open Date: 2018-06-12 Impact factor: 2.692
Authors: Meng Zhao; Yaqi Wang; Shan Wang; Yuan Yang; Ming Li; Kefang Wang Journal: Int J Environ Res Public Health Date: 2022-03-16 Impact factor: 3.390